Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | Chief Operating Officer | April 01, 2022 | April 05, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date April 01, 2022 · Filed April 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,401 |
Reported balance
After 2022-04-01 transaction · row 1
1 source rowRow 1 · 2022-04-01 · Tax withholding · Disposed 384 · Balance 47,401 F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 25,662 | $26.66 | $684,148.92 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:47 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,584 | $8.82 | $31,610.88 |
DisclosureSEC source: 0001214659-20-010490 · marketforms-50637.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,423 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · derivative · entry 12 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,351 Underlying: Common Stock · 3,423 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 135 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · derivative · entry 11 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 135 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,423 | $151.13 | $517,317.99 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 8 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,350 F1 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 9, 2020. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,423 | $8.82 | $30,190.86 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 135 | $151.13 | $20,402.55 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,350 F1 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 9, 2020. Read SEC document |
| December 11, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 135 | $5.95 | $803.25 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,419 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · derivative · entry 10 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,774 Underlying: Common Stock · 3,419 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 131 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · derivative · entry 9 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135 Underlying: Common Stock · 131 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,419 | $138.62 | $473,941.78 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,350 F1 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 9, 2020. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,419 | $8.82 | $30,155.58 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 131 | $138.62 | $18,159.22 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,350 F1 · shares: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 9, 2020. Read SEC document |
| December 10, 2020 Filed Dec 14, 2020 22:42 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 131 | $5.95 | $779.45 |
DisclosureSEC source: 0001214659-20-010387 · marketforms-50625.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:56 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,228 | $115.56 | $141,907.68 |
DisclosureSEC source: 0001214659-20-009879 · marketforms-50161.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,350 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,419 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · derivative · entry 12 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,193 Underlying: Common Stock · 3,419 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 131 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · derivative · entry 11 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266 Underlying: Common Stock · 131 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,419 | $107.20 | $366,516.80 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 8 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,578 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,419 | $8.82 | $30,155.58 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 131 | $107.20 | $14,043.20 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,578 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 131 | $5.95 | $779.45 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,419 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · derivative · entry 10 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,612 Underlying: Common Stock · 3,419 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 131 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · derivative · entry 9 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397 Underlying: Common Stock · 131 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,419 | $102.90 | $351,815.10 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,578 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,419 | $8.82 | $30,155.58 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 131 | $102.90 | $13,479.90 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,578 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| November 12, 2020 Filed Nov 16, 2020 22:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 131 | $5.95 | $779.45 |
DisclosureSEC source: 0001214659-20-009617 · marketforms-50123.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 20:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 1,121 | $85.97 | $96,372.37 |
DisclosureSEC source: 0001214659-20-008874 · marketforms-49871.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,578 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,419 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · derivative · entry 12 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,031 Underlying: Common Stock · 3,419 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 131 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · derivative · entry 11 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528 Underlying: Common Stock · 131 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,419 | $86.63 | $296,187.97 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 8 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,699 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,419 | $8.82 | $30,155.58 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 131 | $86.63 | $11,348.53 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,699 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 131 | $5.95 | $779.45 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,419 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · derivative · entry 10 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,450 Underlying: Common Stock · 3,419 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 131 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · derivative · entry 9 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659 Underlying: Common Stock · 131 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,419 | $89.58 | $306,274.02 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,699 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,419 | $8.82 | $30,155.58 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 3 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 131 | $89.58 | $11,734.98 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 2 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,699 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:09 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 131 | $5.95 | $779.45 |
DisclosureSEC source: 0001214659-20-008565 · marketforms-49848.xml · nonDerivative · entry 1 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,419 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · derivative · entry 13 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,869 Underlying: Common Stock · 3,419 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 131 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · derivative · entry 12 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 790 Underlying: Common Stock · 131 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,419 | $65.21 | $222,952.99 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 9 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,699 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 3,419 | $8.82 | $30,155.58 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 8 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,118 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 131 | $65.21 | $8,542.51 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 7 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,699 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 18, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionCommon Stock | 131 | $5.95 | $779.45 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 6 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,419 | $0.00 Strike: $8.82 | $0.00 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · derivative · entry 11 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,288 Underlying: Common Stock · 3,419 shares Expires 2027-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 131 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · derivative · entry 10 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 921 Underlying: Common Stock · 131 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,571 | $60.75 | $459,938.25 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 5 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,699 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 20:58 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,419 | $60.75 | $207,704.25 |
DisclosureSEC source: 0001214659-20-008002 · marketforms-49689.xml · nonDerivative · entry 4 Weiss Patrick · CIK 0001755793 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,270 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.